Real-time prediction of mediastinal lymph node malignancy by endobronchial ultrasound
Arch Bronconeumol. 2014 Jun;50(6):228-34.
doi: 10.1016/j.arbres.2013.12.002.
Epub 2014 Feb 8.
[Article in
English,
Spanish]
Authors
Hanaa Shafiek
1
, Federico Fiorentino
2
, Alejandro David Peralta
2
, Enrique Serra
3
, Blanca Esteban
3
, Rocío Martinez
2
, Maria Angels Noguera
2
, Pere Moyano
4
, Ernest Sala
5
, Jaume Sauleda
5
, Borja G Cosío
6
Affiliations
- 1 Departamento de Medicina Respiratoria, Hospital Universitario Son Espases, Palma de Mallorca, España; Departamento de Enfermedades del Tórax, Facultad de Medicina, Universidad de Alejandría, Alejandría, Egipto.
- 2 Departamento de Medicina Respiratoria, Hospital Universitario Son Espases, Palma de Mallorca, España.
- 3 Departamento de Anatomía Patológica, Hospital Universitario Son Espases, Palma de Mallorca, España.
- 4 Departamento de Anestesiología, Hospital Universitario Son Espases, Palma de Mallorca, España.
- 5 Departamento de Medicina Respiratoria, Hospital Universitario Son Espases, Palma de Mallorca, España; Ciber de Enfermedades Respiratorias (Ciberes), España.
- 6 Departamento de Medicina Respiratoria, Hospital Universitario Son Espases, Palma de Mallorca, España; Ciber de Enfermedades Respiratorias (Ciberes), España. Electronic address: [email protected].
Abstract
Objective:
To evaluate the utility of different ultrasonographic (US) features in differentiating benign and malignant lymph node (LN) by endobronchial ultrasound (EBUS) and validate a score for real-time clinical application.
Methods:
208 mediastinal LN acquired from 141 patients were analyzed. Six different US criteria were evaluated (short axis ≥10 mm, shape, margin, echogenicity, and central hilar structure [CHS], and presence of hyperechoic density) by two observers independently. A simplified score was generated where the presence of margin distinction, round shape and short axis ≥10 mm were scored as 1 and heterogeneous echogenicity and absence of CHS were scored as 1.5. The score was evaluated prospectively for real-time clinical application in 65 LN during EBUS procedure in 39 patients undertaken by two experienced operators. These criteria were correlated with the histopathological results and the sensitivity, specificity, positive and negative predictive values (PPV and NPV) were calculated.
Results:
Both heterogenicity and absence of CHS had the highest sensitivity and NPV (≥90%) for predicting LN malignancy with acceptable inter-observer agreement (92% and 87% respectively). On real-time application, the sensitivity and specificity of the score >5 were 78% and 86% respectively; only the absence of CHS, round shape and size of LN were significantly associated with malignant LN.
Conclusions:
Combination of different US criteria can be useful for prediction of mediastinal LN malignancy and valid for real-time clinical application.
Keywords:
Ecografía endobronquial; Endobronchial ultrasound; Estadificación de cáncer de pulmón; Ganglio linfático mediastínico; Lung cancer staging; Mediastinal lymph node.
Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.
MeSH terms
-
Aged
-
Biopsy, Needle / methods
-
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
-
Carcinoma, Non-Small-Cell Lung / secondary*
-
Computer Systems*
-
Endosonography*
-
Female
-
Humans
-
Lung Neoplasms / diagnostic imaging*
-
Lung Neoplasms / pathology
-
Lymph Nodes / pathology
-
Lymphatic Metastasis / diagnostic imaging*
-
Male
-
Middle Aged
-
Neoplasm Staging / methods*
-
Observer Variation
-
Positron-Emission Tomography
-
Prospective Studies
-
Retrospective Studies
-
Sensitivity and Specificity
-
Severity of Illness Index
-
Tomography, X-Ray Computed